首页> 外文期刊>Experimental and clinical transplantation >Parathyroid Allotransplant With a New Technique: A Prospective Clinical Trial
【24h】

Parathyroid Allotransplant With a New Technique: A Prospective Clinical Trial

机译:甲状旁腺异体移植的新技术:一项前瞻性临床试验

获取原文
       

摘要

Objectives: Parathyroid allotransplant is a valuable alternative in treating permanent hypoparathy-roidism. However, it is a difficult process that requires several trained staff and advanced laboratory equipment, which makes the costs high. Here, we identify a new parathyroid allotransplant technique. Materials and Methods: After obtaining informed consent from patients, parathyroid cell suspensions obtained from 4 donors who had undergone a subtotal parathyroidectomy owing to chronic renal failure were transplanted in 10 patients with permanent hypoparathyroidism after short-term cell cultivation. Prednisolone were used as immuno-suppressant for the first 10 days and discontinued thereafter. Results: Allograft function was observed in 7 patients (70%) at a mean follow-up of 12 months. Daily oral calcium and vitamin D supplementations discontinued totally in 7 patients. No major or minor complication was observed. Conclusions: Our technique is simple, fast, and has a low cost, with a 70% success rate at a mean follow-up of 12 months. It requires few staff, minimal equipment, and short-term immunosuppressant use for maintenance. The technical developments of parathyroid allotransplant, as mentioned in this study, may be important in treating permanent hypoparathyroidism.
机译:目的:甲状旁腺异体移植是治疗永久性甲状旁腺功能减退的一种有价值的替代方法。然而,这是一个困难的过程,需要几个训练有素的人员和先进的实验室设备,这使成本很高。在这里,我们确定了一种新的甲状旁腺同种异体移植技术。材料和方法:在征得患者的知情同意后,将4位因慢性肾功能衰竭而进行了次全副甲状腺切除术的供体获得的甲状旁腺细胞悬液移植到10名经过短期细胞培养的永久性甲状旁腺功能低下的患者中。泼尼松龙在头10天用作免疫抑制剂,此后停用。结果:7例患者(70%)观察到同种异体移植功能,平均随访12个月。 7例患者每日完全停止口服钙和维生素D补充剂。没有观察到大或小并发症。结论:我们的技术简单,快速且成本低廉,平均随访12个月成功率达70%。它需要很少的人员,最少的设备和短期的免疫抑制剂来进行维护。如本研究所述,甲状旁腺异体移植的技术发展可能对治疗永久性甲状旁腺功能低下很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号